Eflucimibe

Eflucimibe (F 12511) is a new acyl-coenzyme A cholesterol O-acyltransferase (ACAT) inhibitor. Eflucimibe can be used in the research of atherosclerosis[1].

Product Specifications

CAS Number

[202340-45-2]

Product Name Alternative

F 12511

UNSPSC

12352005

Target

Acyltransferase

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/eflucimibe.html

Purity

98.60

Solubility

DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

CC(C(C)=C(C(C)=C1)O)=C1NC([C@H](C2=CC=CC=C2)SCCCCCCCCCCCC)=O

Molecular Formula

C29H43NO2S

Molecular Weight

469.72

References & Citations

[1]Nathalie Mesplet, et al. Analysis of eflucimibe and related impurities by highly sensitive liquid chromatography-electrospray-tandem mass spectrometry. The Journal of Separation Science. 2003.